Company intelligence
NAS Healthcare Solutions
Consultancy providing strategic insights for Market Access
Pharmaceutical Manufacturing
London, GB
1 employee
Founded 2013
4 public signals
About NAS Healthcare Solutions
NAS Healthcare Solutions is consultancy which offers strategic support for European Market Access to the pharmaceutical industry. The company owner and Director, Natalie Shalet, has 14 years experience working alongside the pharmaceutical industry, and as such operates as a freelance contractor through NAS Healthcare Solutions.
Verified activity
Signals from NAS Healthcare Solutions
4 published signals
Legal & Regulatory
NAS Healthcare Solutions notes that the first JCA published in June 2026 for tovorfenib and two more for tarlatamab and lurbinectedin following in July, requiring member states to consider these outputs in pricing and reimbursement decisions.
Reported by Natalie Shalet
Legal & Regulatory
NAS Healthcare Solutions notes that Slovakia is advancing legislation to expand access to high-priced orphan and paediatric treatments, part of a broader European trend where national frameworks are adapting faster than EU-level harmonisation.
Reported by Natalie Shalet
Legal & Regulatory
NAS Healthcare Solutions highlights that the MHRA proposed IMA pathway for ultra-rare conditions could shorten time-to-access for rare diseases, consultation closed on 30 July 2026, and adoption could lead to earlier access subject to NICE assessment on NHS use.
Reported by Natalie Shalet